pipette
ESEspañol

Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia

Siyu Liu, Ayesha Ejaz, Andrew John King, Aude-Anaïs Olijnik, Jacqueline A. Sloane-Stanley, Caroline Scott, Ali Amid, Daniel Biggs, Benjamin Davies, Jennifer Eglinton, Gabriella Martyn, Merlin Crossley, Christian Babbs, Mira T. Kassouf, Douglas R. Higgs

Peer-reviewed journalReal-world use

In the authors' words

Abstract Hemoglobinopathies are the most common inherited anemias worldwide. While most carriers are asymptomatic or mildly affected, severe forms of α-thalassemia, including severe hemoglobin H (HbH) disease and surviving individuals with Hb Bart’s hydrops fetalis syndrome (BHFS), require lifelong transfusion support or stem cell transplantation. Reactivating the silenced embryonic α-like globin (ζ-globin) gene is a promising approach for treating these diseases. Here we identify the key cis -regulatory elements responsible for silencing the ζ-globin gene in definitive erythroid cells and subsequently develop gene-editing strategies that reactivate ζ-globin expression to therapeutically relevant levels. In a preclinical mouse model of BHFS, we show that this strategy rescues the otherwise prenatal lethal condition until late in development (E17.5). Using primary erythroid cells derived from patients with HbH disease and BHFS, we show that these approaches reactivate ζ-globin expression to levels exceeding those achieved in the mouse model, producing therapeutic levels of α-like globin.

Main resultThe abstract does not state a limitation.

Appeared: Saturday, October 3. Nature Genetics. Peer-reviewed journal.

DOI: 10.1038/s41588-026-02770-0